Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
streptococcus thermophilus KB27 + lactobacillus acidophilus KB31 + bifidobacterium longum KB35
- Development stage
- Unknown
- Lead developer
- Kibow Biotech
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Renadyl is a proprietary probiotic formulation developed by Kibow Biotech, consisting of three specific strains: *Streptococcus thermophilus* KB27, *Lactobacillus acidophilus* KB31, and *Bifidobacterium longum* KB35. It is designed to support kidney function by utilizing "enteric dialysis," a process where probiotic bacteria metabolize nitrogenous wastes (such as urea, uric acid, and creatinine) in the colon, thereby reducing the burden on impaired kidneys. It is primarily marketed as a dietary supplement for patients with chronic kidney disease (CKD) and has been evaluated in clinical trials for its ability to improve quality of life and reduce toxin levels in patients with renal failure. The formulation is also marketed for veterinary use under the brand name Azodyl for the management of azotemia in dogs and cats.
- Brand names
- RenadylAzodyl
- Other names
- Kibow BioticsEnteric Dialysis probiotic
02
Targets
PCS (p-Cresyl sulfate)IS (Indoxyl sulfate)
Beyond the preview
Go deeper on streptococcus thermophilus KB27 + lactobacillus acidophilus KB31 + bifidobacterium longum KB35.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on streptococcus thermophilus KB27 + lactobacillus acidophilus KB31 + bifidobacterium longum KB35.